Muestra la distribución de la producción WoS, Scopus y SciELO del autor.
Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.
| Firmas del autor | |
| Nombre | TERESA VALENZUELA, MARIA |
| Género | - |
| Área Principal WOS | Immunology; Biotechnology & Applied Microbiology; Medicine, General & Internal; |
| Afiliación Principal | Universidad De Los Andes, Chile |
Publicaciones en Chile
Citas Totales
Afiliaciones Chilenas
| WOS | #Pub |
|---|---|
| Immunology | 3 |
| Biotechnology & Applied Microbiology | 2 |
| Medicine, General & Internal | 1 |
| Medicine, Research & Experimental | 1 |
| Scopus | #Pub |
|---|---|
| Veterinary (All) | 1 |
| Public Health, Environmental And Occupational Health | 1 |
| Infectious Diseases | 1 |
| Molecular Medicine | 1 |
| Immunology And Microbiology (All) | 1 |
| SciELO | #Pub |
|---|
| Autor | Género | # Pub |
|---|---|---|
| ORYAN, M | Hombre | 2 |
| VALENZUELA, MT | Mujer | 4 |
| DE-SANTOLAYA-P, MARIA ELENA | Mujer | 3 |
| SANTOLAYA D, MARIA ELENA | Mujer | 1 |
| VEGA-MORALES, JEANNETTE | Mujer | 1 |
| PRADO-JIMENEZ, VALERIA | Mujer | 2 |
| TORRES-TORRETI, JUAN PABLO | Hombre | 1 |
| VERGARA, RODRIGO | Hombre | 2 |
| CHOMALI, MAY | Mujer | 1 |
| SANTOLAYA, MARIA E. | Mujer | 2 |
| MUNOZ, ALMA | Mujer | 2 |
| IZQUIERDO, GIANNINA | Mujer | 1 |
| Título | Año | Citas | Tipo | Revista | Indexada |
|---|---|---|---|---|---|
| Cost Effectiveness Analysis Of A Multicomponent Meningococcal Serogroup B Vaccine In Hypothetic Epidemic Situation In A Middle Income Country | 2015 | 12 | artículo de investigación | Human Vaccines & Immunotherapeutics | WoS Scopus |
| Persistence Of Antibodies In Adolescents 18 24 Months After Immunization With One, Two, Or Three Doses Of 4 C Men B Meningococcal Serogroup B Vaccine | 2013 | 58 | artículo de investigación | Human Vaccines & Immunotherapeutics | WoS Scopus |
| Immunogenicity And Tolerability Of A Multicomponent Meningococcal Serogroup B (4 C Men B) Vaccine In Healthy Adolescents In Chile: A Phase 2b/3 Randomised, Observer Blind, Placebo Controlled Study | 2012 | 180 | artículo de investigación | Lancet | WoS Scopus |
| Antibiotic Resistance In Latin America: A Cause For Alarm | 2009 | 19 | artículo de investigación | Vaccine | WoS Scopus |
| Palabra Clave | #Pub |
|---|---|
| neisseria-meningitidis | 3 |
| immunogenicity | 2 |
| chile | 2 |
| quantitative assessment | 1 |
| meningococcal disease | 1 |
| meningococcal vaccine | 1 |
| multicomponent | 1 |
| neisseria meningitidis | 1 |
| nmen | 1 |
| outbreak | 1 |
| pcv7 | 1 |
| penicillin resistance | 1 |
| persistence | 1 |
| prevalence | 1 |
| meningitis | 1 |
| recombinant | 1 |
| serogroup b | 1 |
| serogroup b meningococcal vaccine | 1 |
| strain coverage | 1 |
| streptococcus pneumoniae | 1 |
| streptococcus-pneumoniae | 1 |
| surveillance | 1 |
| trial | 1 |
| united-states | 1 |
| vaccine | 1 |
| cost-effectiveness analysis | 1 |
| adolescents | 1 |
| antibiotic resistance | 1 |
| antibodies | 1 |
| antibody | 1 |
| antimicrobial resistance | 1 |
| binding-protein | 1 |
| c conjugate vaccination | 1 |
| campaign | 1 |
| cerebrospinal fluid | 1 |
| conjugate vaccine | 1 |
| meningococcal | 1 |
| coverage | 1 |
| csf | 1 |
| disease | 1 |
| england | 1 |
| gdp | 1 |
| gross domestic product | 1 |
| immunity | 1 |
| impact | 1 |
| md | 1 |
| 4cmenb | 1 |